Revolutionizing the treatment for Tricuspid Regurgitation that can save lives of millions of patients globally.
Tricuspid Regurgitation: A heart valve problem affecting >20 million patients
The TriSail Solution
The simplest and fastest minimally invasive transcatheter repair device to treat patients suffering from tricuspid regurgitation. TriSail’s artificial single leaflet-like spacer structure placed inside the valve blocks backflow of blood and corrects TR in a consistent & reliable way. Trisail has been designed to make it the simplest device to maximize adoption rates to treat TR in a safe, predicatable and fast procedure
The invention
The TriSail concept was originally invented by Prof. Khung Keong YEO, an internationally renowned interventional cardiologist and key opinion leader in the field of heart valve interventions, and colleagues at the National Heart Centre Singapore, and was spun-out to further develop and commercialize the technology
Meet the Team
-
Prof. Khung Keong YEO
CO-FOUNDER, CARDIOLOGIST
Inventor, Clinical advisor, Senior consultant Cardiologist at NHCS. International KOL in Mitral & Tricuspid valve interventions
-
Dr. Srinivas (Sri) Bhylahalli
CO-FOUNDER, CEO
PhD, MS, MBA; Medtech executive,16 years experience in BD, Commercialization, Venture building. Previous founder/CEO roles in Anatomics (Asia), UAMC, Intellimed Healthcare.
-
James Watson, PE
CO-FOUNDER, CTO
25 years experience in medical device development & clinical studies, including in companies such as Medtronic, TriVascular and Boston Scientific.
-
Chris Minar
Strategy & Operations
25+ years medical device experience, Founder/CEO of Neuraworx, Intershunt; Senior executive roles at St.Jude Medical, Stereotaxis, Integer, others.
Get in Touch
Excited about our innovative solution for Tricuspid regurgitation? Share your details below, and our team will reach out to you promptly. We look forward to connecting with you!